Cadila Healthcare informs about press release

06 Jul 2020 Evaluate

Cadila Healthcare has informed that it has enclosed a Press Release dated July 6, 2020 titled ‘Zydus receives approval from COFERIS, Mexico to study Desidustat in the management of COVID-19’. The contents of the Press Release give full details. Bring the aforesaid news to the notice of the members of the exchange and investors’ at large.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

953.50 20.10 (2.15%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.